Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 8,899 | 13,205 | 11,566 | 11,213 | 9,167 |
| Cost of Goods | 1,230 | 1,762 | 1,906 | 1,802 | 1,495 |
| Gross Profit | 7,669 | 11,443 | 9,660 | 9,411 | 7,672 |
| Operating Expenses | 16,310 | 15,476 | 19,580 | 17,545 | 15,496 |
| Operating Income | -8,411 | -3,271 | -9,014 | -7,332 | -7,329 |
| Interest Expense | 1,436 | 1,452 | 1,460 | 1,423 | 1,209 |
| Other Income | 11,390 | -5,030 | -332 | 464 | -1,832 |
| Pre-tax Income | 1,543 | -9,753 | -10,806 | -8,291 | -10,370 |
| Income Tax | -4 | 0 | -5 | 3 | -5 |
| Net Income Continuous | 1,547 | -9,753 | -10,801 | -8,294 | -10,365 |
| Net Income | $1,539 | $-9,753 | $-10,811 | $-8,288 | $-10,375 |
| EPS Basic Total Ops | 0.03 | -0.22 | -0.96 | -0.27 | -0.39 |
| EPS Basic Continuous Ops | 0.03 | -0.17 | -0.25 | -0.25 | -0.36 |
| EPS Diluted Total Ops | 0.03 | -0.22 | -0.96 | -0.27 | -0.39 |
| EPS Diluted Continuous Ops | 0.03 | -0.17 | -0.25 | -0.25 | -0.36 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.12 | -0.96 | -0.27 | -0.33 |
| EBITDA(a) | $-7,980 | $-2,863 | $-8,576 | $-6,910 | $-6,922 |